Luskin Marlise R, Discenza Marie N, Easter Sarah Rae, Dal Cin Paola, Owen Renius, Ilagan Bernard, Masiello Meredith, Lane Andrew A
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Harvard Medical School, Boston, MA.
Blood Adv. 2017 Aug 15;1(19):1491-1494. doi: 10.1182/bloodadvances.2017008680. eCollection 2017 Aug 22.
cfDNA sequencing for fetal aneuploidy may detect chromosomal abnormalities representative of maternal malignancy.Maternal malignancy must be considered when abnormal cfDNA sequencing for fetal aneuploidy is associated with normal fetal karyotype.
用于胎儿非整倍体检测的cfDNA测序可能会检测到代表母体恶性肿瘤的染色体异常。当胎儿非整倍体的cfDNA测序结果异常而胎儿核型正常时,必须考虑母体恶性肿瘤的可能性。